Trillium Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-849
| Closed | -$252K | – | 236 |
|
|
2019
Q4 | $252K | Sell |
849
-592
| -41% | -$164K | 0.01% | 243 |
|
|
2019
Q3 | $336K | Buy |
1,441
+358
| +33% | +$83.4K | 0.02% | 226 |
|
|
2019
Q2 | $253K | Sell |
1,083
-20,831
| -95% | -$4.81M | 0.01% | 217 |
|
|
2019
Q1 | $5.18M | Sell |
21,914
-11,782
| -35% | -$3.71M | 0.26% | 113 |
|
|
2018
Q4 | $10.1M | Sell |
33,696
-1,482
| -4% | -$473K | 0.59% | 65 |
|
|
2018
Q3 | $12.4M | Buy |
35,178
+323
| +0.9% | +$111K | 0.62% | 61 |
|
|
2018
Q2 | $10.1M | Sell |
34,855
-209
| -0.6% | -$58.8K | 0.54% | 73 |
|
|
2018
Q1 | $9.6M | Buy |
35,064
+498
| +1% | +$155K | 0.53% | 72 |
|
|
2017
Q4 | $11M | Sell |
34,566
-499
| -1% | -$160K | 0.61% | 69 |
|
|
2017
Q3 | $11M | Sell |
35,065
-3,170
| -8% | -$939K | 0.63% | 64 |
|
|
2017
Q2 | $10.4M | Buy |
38,235
+266
| +0.7% | +$70.3K | 0.62% | 65 |
|
|
2017
Q1 | $10.4M | Sell |
37,969
-797
| -2% | -$225K | 0.66% | 60 |
|
|
2016
Q4 | $11M | Sell |
38,766
-1,998
| -5% | -$592K | 0.72% | 57 |
|
|
2016
Q3 | $12.8M | Sell |
40,764
-1,936
| -5% | -$573K | 0.82% | 47 |
|
|
2016
Q2 | $10.3M | Sell |
42,700
-3,087
| -7% | -$814K | 0.68% | 62 |
|
|
2016
Q1 | $11.9M | Buy |
45,787
+126
| +0.3% | +$33.3K | 0.79% | 46 |
|
|
2015
Q4 | $14M | Sell |
45,661
-877
| -2% | -$252K | 0.95% | 32 |
|
|
2015
Q3 | $13.6M | Buy |
46,538
+10,887
| +31% | +$3.6M | 0.95% | 35 |
|
|
2015
Q2 | $14.4M | Buy |
35,651
+11,920
| +50% | +$4.78M | 0.92% | 37 |
|
|
2015
Q1 | $10M | Buy |
23,731
+5,431
| +30% | +$2.14M | 0.65% | 58 |
|
|
2014
Q4 | $6.21M | Buy |
+18,300
| New | +$5.92M | 0.42% | 98 |
|
Other funds holding BIIB
